SAHPRA Terminates Ivermectin COVID-19 Access Program: Last Nail in the Coffin?

Join The Conversation! | https://trialsitenews.com/
South Africa’s drug regulator has terminated its controversial COVID-19 ivermectin program. The South African Health Products Regulatory Authority (SAHPRA) will no longer allow importation of unrecovered ivermectin products, nor can health facilities hold bulk ivermectin stock in anticipation of prescriptions for the unregistered products. The controversial “Section 21” approval program is gone, and with it, a piece of South African history. And now, Culminating with this victorious lawsuit with bittersweet real-world implications, SAHPRA has appeared to pound the last nail in ivermectin’s COVID-19 coffin. At least in this part of the world.